Literature DB >> 21921364

Protective effect of ambroxol against paraquat-induced pulmonary fibrosis in rats.

Qiao-Ming Zhi1, Li-Tao Yang, Hai-chen Sun.   

Abstract

OBJECTIVE: To evaluate the possible therapeutic effect of ambroxol on pulmonary fibrosis induced by paraquat.
METHODS: Adult male Sprague-Dawley rats (n=144, 200-250 g) were divided into four groups (Control, Ambroxol, Paraquat, and Paraquat+Ambroxol group) and sacrificed on day 1, 3, 5, 7, 14 and 28. Several significant oxidant stress markers (MDA, SOD and GSH-PX), MPO activity, cytokines (TNF-α, MCP-1, TGF-β1, MMP-2 and TIMP-1), total inflammatory cell count, hydroxyproline content, collagen I and III mRNA were analyzed.
RESULTS: In Paraquat group, the MDA, MPO activity, hydroxyproline contents, the mRNA expression of TNF-α, MCP-1, TGF-β1, MMP-2, TIMP-1, collagen I, collagen III and the number of total inflammatory cells were up-regulated in lung tissue, but SOD and GSH-PX activity were down-regulated in lung tissue compared with Control group (p<0.05). In paraquat+ambroxol group, the MDA, MPO activity, hydroxyproline content, the mRNA expression of TNF-α, MCP-1, TGF-β1, MMP-2, TIMP-1 collagen I, collagen III and the number of total inflammatory cells were significantly decreased, while the SOD and GSH-PX activities in lung tissue were increased compared with Paraquat group (p<0.05). Histological examination of paraquat-treated rats showed lung injury with interstitial edema and widespread inflammatory cell infiltration in the alveolar space and septum, as well as pulmonary fibrosis. Ambroxol could markedly reduce such damage in lung tissue and prevent pulmonary fibrosis.
CONCLUSION: The results of this study indicated that ambroxol could reduce lung damage and prevent pulmonary fibrosis induced by paraquat.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921364     DOI: 10.2169/internalmedicine.50.5407

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Edaravone decreases paraquat toxicity in a549 cells and lung isolated mitochondria.

Authors:  Mohammad Shokrzadeh; Fatemeh Shaki; Ebrahim Mohammadi; Neda Rezagholizadeh; Fatemeh Ebrahimi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

2.  Effect of ambroxol on the concentration of cefotaxime in the bronchoalveolar lavage fluid of rats with pulmonary fibrosis.

Authors:  Feng Chen; Yuan-Xia Zhang; Cai-Qing Zhang
Journal:  Exp Ther Med       Date:  2014-12-08       Impact factor: 2.447

3.  Suppressive effects of the expectorant drug ambroxol hydrochloride on quartz-induced lung inflammation in F344 rats.

Authors:  Shohei Kanie; Masanao Yokohira; Keiko Yamakawa; Yuko Nakano-Narusawa; Shota Yoshida; Nozomi Hashimoto; Katsumi Imaida
Journal:  J Toxicol Pathol       Date:  2016-12-22       Impact factor: 1.628

4.  Effects of the expectorant drug ambroxol hydrochloride on chemically induced lung inflammatory and neoplastic lesions in rodents.

Authors:  Shota Yoshida; Masanao Yokohira; Keiko Yamakawa; Yuko Nakano-Narusawa; Shohei Kanie; Nozomi Hashimoto; Katsumi Imaida
Journal:  J Toxicol Pathol       Date:  2018-06-09       Impact factor: 1.628

Review 5.  Characteristics of surfactant proteins in tumorigenic and inflammatory lung lesions in rodents.

Authors:  Masanao Yokohira; Keiko Yamakawa; Yuko Nakano-Narusawa; Nozomi Hashimoto; Shohei Kanie; Shota Yoshida; Katsumi Imaida
Journal:  J Toxicol Pathol       Date:  2018-06-02       Impact factor: 1.628

6.  The dose of cyclophosphamide for treating paraquat-induced rat lung injury.

Authors:  Jae-Sung Choi; Sung-Shick Jou; Mee-Hye Oh; Young-Hee Kim; Min-Ju Park; Hyo-Wook Gil; Ho-Yeon Song; Sae-Yong Hong
Journal:  Korean J Intern Med       Date:  2013-07-01       Impact factor: 2.884

7.  Ambroxol hydrochloride in the management of idiopathic pulmonary fibrosis: Clinical trials are the need of the hour.

Authors:  P R Gupta
Journal:  Lung India       Date:  2014-01

8.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.